Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy

被引:10
作者
Ellis, RJ
Childers, ME
Zimmerman, JD
Frost, SDW
Deutsch, R
McCutchan, JA
机构
[1] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
关键词
D O I
10.1086/375152
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To characterize, over time, cerebrospinal fluid (CSF) virus-load change in clinically stable patients, human immunodeficiency virus (HIV)-1 RNA levels were measured in serial CSF samples and in plasma samples obtained, during periods of 20 days-6 years, from 17 HIV-infected individuals not receiving antiretroviral treatment. Longitudinal trends were analyzed by linear regression and restricted maximum-likelihood techniques. CSF HIV-1 RNA levels varied within a restricted range (+/-0.5 log(10) copies/mL) around each subject-specific mean. Although 16 of the 17 subjects had CSF slopes not significantly different from zero, slopes that were more positive were associated with lower CD4 counts. In an individual patient, a CSF virus-load change >0.5 log(10) copies/mL may be clinically significant. Furthermore, our data suggest that, if the CSF virus load reflects the size of the reservoir of infected cells in the central nervous system, this reservoir may increase in those individuals with advanced immunosuppression but is stable, over several years, in patients without AIDS.
引用
收藏
页码:1818 / 1821
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[2]   The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements [J].
Brambilla, D ;
Reichelderfer, PS ;
Bremer, JW ;
Shapiro, DE ;
Hershow, RC ;
Katzenstein, DA ;
Hammer, SM ;
Jackson, B ;
Collier, AC ;
Sperling, RS ;
Fowler, MG ;
Coombs, RW .
AIDS, 1999, 13 (16) :2269-2279
[3]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[4]   Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days [J].
Deeks, SG ;
Coleman, RL ;
White, R ;
Pachl, C ;
Schambelan, M ;
Chernoff, DN ;
Feinberg, MB .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (02) :514-517
[5]   Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources [J].
Ellis, RJ ;
Gamst, AC ;
Capparelli, E ;
Spector, SA ;
Hsia, K ;
Wolfson, T ;
Abramson, I ;
Grant, I ;
McCutchan, JA .
NEUROLOGY, 2000, 54 (04) :927-936
[6]  
Fishman R.A., 1992, CEREBROSPINAL FLUID, V2nd
[7]   Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment -: A longitudinal study [J].
Gisslén, M ;
Hagberg, L ;
Fuchs, D ;
Norkrans, G ;
Svennerholm, B .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 17 (04) :291-295
[8]  
HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554
[9]   Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels [J].
Martin, C ;
Albert, J ;
Hansson, P ;
Pehrsson, PO ;
Link, H ;
Sonnerborg, A .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (03) :214-219
[10]  
Masel J, 2000, J ACQ IMMUN DEF SYND, V23, P375